Victor F. Tapson

54.6k total citations · 18 hit papers
339 papers, 29.6k citations indexed

About

Victor F. Tapson is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Victor F. Tapson has authored 339 papers receiving a total of 29.6k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Pulmonary and Respiratory Medicine, 156 papers in Internal Medicine and 136 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Victor F. Tapson's work include Venous Thromboembolism Diagnosis and Management (156 papers), Pulmonary Hypertension Research and Treatments (129 papers) and Atrial Fibrillation Management and Outcomes (55 papers). Victor F. Tapson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (156 papers), Pulmonary Hypertension Research and Treatments (129 papers) and Atrial Fibrillation Management and Outcomes (55 papers). Victor F. Tapson collaborates with scholars based in United States, France and Germany. Victor F. Tapson's co-authors include Lewis J. Rubin, Vallerie V. McLaughlin, David B. Badesch, Robyn J. Barst, Samuel Z. Goldhaber, Russell D. Hull, Richard N. Channick, Michael D. McGoon, John G. Weg and Adaani Frost and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Victor F. Tapson

326 papers receiving 28.6k citations

Hit Papers

A Comparison of Continuous Intravenous Epoprostenol (Pros... 1996 2026 2006 2016 1996 2009 2001 2001 2008 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
    1996 2.0k citations Robyn J. Barst, Lewis J. Rubin et al. profile →
  2. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
    2009 1.8k citations Vallerie V. McLaughlin, Stephen L. Archer et al. profile →
  3. Antithrombotic Therapy for Venous Thromboembolic Disease
    2001 1.4k citations Thomas M. Hyers, Russell D. Hull et al. CHEST Journal profile →
  4. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
    2001 1.1k citations Richard N. Channick, Ivan M. Robbins et al. profile →
  5. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
    2008 1.1k citations Victor F. Tapson et al. profile →
  6. Multidetector Computed Tomography for Acute Pulmonary Embolism
    2006 1.0k citations Charles A. Hales, Russell D. Hull et al. profile →
  7. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
    2009 844 citations Vallerie V. McLaughlin, Stephen L. Archer et al. Circulation profile →
  8. Selexipag for the Treatment of Pulmonary Arterial Hypertension
    2015 706 citations Richard N. Channick, Nazzareno Galiè et al. profile →
  9. Acute Pulmonary Embolism
    2008 635 citations Victor F. Tapson profile →
  10. Sitaxsentan Therapy for Pulmonary Arterial Hypertension
    2003 540 citations Robyn J. Barst, David Langleben et al. American Journal of Respiratory and Critical Care Medicine profile →
  11. Chronic thromboembolic pulmonary hypertension
    2018 473 citations Victor F. Tapson, Hossein Ardeschir Ghofrani et al. European Respiratory Journal profile →
  12. Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension
    2006 454 citations Vallerie V. McLaughlin, Ronald J. Oudiz et al. American Journal of Respiratory and Critical Care Medicine profile →
  13. Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
    2013 436 citations Russell D. Hull, Victor F. Tapson et al. profile →
  14. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
    2013 411 citations Marius M. Hoeper, Robyn J. Barst et al. Circulation profile →
  15. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    2021 336 citations Jeremy Feldman, Victor F. Tapson et al. profile →
  16. A Prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism
    2019 328 citations Thomas Tu, Victor F. Tapson et al. profile →
  17. A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism
    2018 303 citations Victor F. Tapson et al. profile →
  18. Indigo Aspiration System for Treatment of Pulmonary Embolism
    2021 191 citations Victor F. Tapson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victor F. Tapson United States 79 16.0k 15.4k 11.3k 5.2k 3.7k 339 29.6k
Gérald Simonneau France 116 30.4k 1.9× 48.1k 3.1× 6.6k 0.6× 7.9k 1.5× 5.2k 1.4× 567 58.8k
Menno V. Huisman Netherlands 76 15.5k 1.0× 3.2k 0.2× 20.0k 1.8× 5.8k 1.1× 3.3k 0.9× 469 29.6k
Gary E. Raskob United States 58 11.1k 0.7× 2.9k 0.2× 13.3k 1.2× 4.8k 0.9× 1.8k 0.5× 170 19.6k
Harry R. Büller Netherlands 92 18.6k 1.2× 2.7k 0.2× 24.6k 2.2× 8.6k 1.6× 3.5k 0.9× 450 35.7k
Samuel Z. Goldhaber United States 100 27.6k 1.7× 5.4k 0.3× 35.0k 3.1× 10.6k 2.0× 6.6k 1.8× 614 47.4k
John A. Heit United States 68 15.2k 0.9× 3.2k 0.2× 23.7k 2.1× 9.3k 1.8× 2.5k 0.7× 220 30.9k
David Bergqvist Sweden 69 12.8k 0.8× 8.1k 0.5× 14.2k 1.3× 11.8k 2.3× 1.8k 0.5× 741 27.7k
Stavros Konstantinides Germany 68 9.4k 0.6× 2.8k 0.2× 11.4k 1.0× 2.7k 0.5× 4.7k 1.3× 452 18.3k
Michael Gent Canada 90 20.2k 1.3× 4.3k 0.3× 16.1k 1.4× 9.1k 1.7× 5.7k 1.5× 230 34.9k
Sam Schulman Canada 69 21.5k 1.3× 2.1k 0.1× 21.5k 1.9× 7.1k 1.4× 3.6k 1.0× 501 34.5k

Countries citing papers authored by Victor F. Tapson

Since Specialization
Citations

This map shows the geographic impact of Victor F. Tapson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor F. Tapson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor F. Tapson more than expected).

Fields of papers citing papers by Victor F. Tapson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor F. Tapson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor F. Tapson. The network helps show where Victor F. Tapson may publish in the future.

Co-authorship network of co-authors of Victor F. Tapson

This figure shows the co-authorship network connecting the top 25 collaborators of Victor F. Tapson. A scholar is included among the top collaborators of Victor F. Tapson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor F. Tapson. Victor F. Tapson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matusov, Yuri, Samuel H. Pepkowitz, Donald G. Stein, et al.. (2021). Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19. CHEST Journal. 160(1). 74–84. 36 indexed citations
3.
Jaber, Wissam, Christopher Kabrhel, Kenneth Rosenfield, et al.. (2020). Percutaneous Thrombectomy in Emergency Department Patients with Pulmonary Embolism: The FLARE ED Sub-study. Journal of Emergency Medicine. 58(2). 175–182. 8 indexed citations
4.
Dahhan, Talal, Victor F. Tapson, Eric J. Velazquez, et al.. (2016). Clinical and echocardiographic predictors of mortality in acute pulmonary embolism. Cardiovascular Ultrasound. 14(1). 44–44. 56 indexed citations
5.
Jiménez, David, Victor F. Tapson, Beau Briese, et al.. (2014). Derivation and Validation of Multimarker Prognostication for Normotensive Patients with Acute Symptomatic Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine. 189(6). 718–726. 137 indexed citations
6.
Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138. 411 indexed citations breakdown →
7.
Leung, Ann N., Todd Bull, Roman Jaeschke, et al.. (2011). An Official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline: Evaluation of Suspected Pulmonary Embolism In Pregnancy. American Journal of Respiratory and Critical Care Medicine. 184(10). 1200–1208. 123 indexed citations
8.
Hoeper, Marius M., Robyn J. Barst, Nazzareno Galiè, et al.. (2011). Imatinib in pulmonary arterial hypertension, a randomized, efficacy study (IMPRES). European Respiratory Journal. 38(Suppl 55). 413–413. 11 indexed citations
9.
Clements, Philip J., Mary Tan, Vallerie V. McLaughlin, et al.. (2011). The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Annals of the Rheumatic Diseases. 71(2). 249–252. 54 indexed citations
10.
Badesch, David B., Michael D. McGoon, Victor F. Tapson, et al.. (2009). Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol. The Journal of Rheumatology. 36(10). 2244–2249. 59 indexed citations
11.
McLaughlin, Vallerie V., Stephen L. Archer, David B. Badesch, et al.. (2009). ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension. Circulation. 119(16). 2250–2294. 844 indexed citations breakdown →
12.
Zhu, Shoukang, Bin Yan, Thomas J. Povsic, et al.. (2008). Transcriptional Regulation of Bim by FOXO3a and Akt Mediates Scleroderma Serum–Induced Apoptosis in Endothelial Progenitor Cells. Circulation. 118(21). 2156–2165. 68 indexed citations
13.
McLaughlin, Vallerie V., Ronald J. Oudiz, Adaani Frost, et al.. (2006). Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 174(11). 1257–1263. 454 indexed citations breakdown →
14.
Piovella, Franco, Andrea Maria D’Armini, Marisa Barone, & Victor F. Tapson. (2006). Chronic Thromboembolic Pulmonary Hypertension. Seminars in Thrombosis and Hemostasis. 32(8). 848–855. 25 indexed citations
15.
Gomberg‐Maitland, Mardi, Victor F. Tapson, Raymond L. Benza, et al.. (2005). Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 172(12). 1586–1589. 174 indexed citations
16.
Barst, Robyn J., David Langleben, Adaani Frost, et al.. (2003). Sitaxsentan Therapy for Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 169(4). 441–447. 540 indexed citations breakdown →
17.
Tapson, Victor F., B A Carroll, Bruce L. Davidson, et al.. (1999). The Diagnostic Approach to Acute Venous Thromboembolism: Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine. 160(3). 1043–1066. 225 indexed citations
18.
McAdams, H. Page, John G. Murray, Jeremy J. Erasmus, et al.. (1997). Telescoping bronchial anastomoses for unilateral or bilateral sequential lung transplantation: CT appearance.. Radiology. 203(1). 202–206. 14 indexed citations
19.
Layish, Daniel & Victor F. Tapson. (1997). New imaging techniques for the diagnosis of pulmonary embolism. Current Opinion in Pulmonary Medicine. 3(4). 280–285. 4 indexed citations
20.
Gaynor, J. William, et al.. (1996). Survival Benefits of Heart and Lung Transplantation. Annals of Surgery. 223(5). 576–584. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gérald Simonneau Breakdown of academic impact, for papers by Menno V. Huisman Breakdown of academic impact, for papers by Gary E. Raskob Breakdown of academic impact, for papers by Harry R. Büller Breakdown of academic impact, for papers by Samuel Z. Goldhaber Breakdown of academic impact, for papers by John A. Heit Breakdown of academic impact, for papers by David Bergqvist Breakdown of academic impact, for papers by Stavros Konstantinides Breakdown of academic impact, for papers by Michael Gent Breakdown of academic impact, for papers by Sam Schulman
Rankless by CCL
2026